Range Impact (RNGE) director awarded 250,000 stock options at $0.15 exercise price

Rhea-AI Filing Summary

Range Impact, Inc. director Edward F. Feighan reported a new equity award in the form of stock options. On December 31, 2025, he was granted options to purchase 250,000 shares of common stock at an exercise price of $0.15 per share, with the option vesting immediately. Following this grant, he beneficially owned stock options relating to 2,333,000 derivative securities in total, all held directly. This reflects an incentive-based compensation grant rather than a market purchase or sale of existing shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider FEIGHAN EDWARD F

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	250,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 2,333,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FEIGHAN EDWARD F

(Last) (First) (Middle)

200 PARK AVENUE, SUITE 400

(Street)

CLEVELAND, OH 44122

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RANGE IMPACT, INC. [ RNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.15	12/31/2025(1)		A		250,000		12/31/2025	12/31/2035	Common Stock	250,000	$0.00	2,333,000	D

Explanation of Responses:

1. On December 31, 2025, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.15. This option vested immediately.

	/s/ Edward Feighan	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Range Impact (RNGE) disclose for Edward F. Feighan?

Range Impact disclosed that director Edward F. Feighan received a grant of stock options on December 31, 2025 covering 250,000 shares of common stock.

What is the exercise price of the new stock options granted to the RNGE director?

The options granted to the Range Impact director have an exercise price of $0.15 per share, as stated in the grant terms.

Did the new Range Impact (RNGE) stock options to Edward Feighan vest immediately?

Yes. The footnote explains that the options to purchase 250,000 shares at $0.15 per share vested immediately on December 31, 2025.

How many derivative securities does Edward Feighan hold after this RNGE option grant?

After the grant, Edward Feighan beneficially owned 2,333,000 derivative securities related to Range Impact common stock, all reported as held directly.

Was this Range Impact (RNGE) insider transaction a purchase or sale in the market?

No. The reported Form 4 transaction is an option grant (coded "A" for acquisition) with a price of $0.00 for the option itself and an exercise price of $0.15 per share, not a market purchase or sale of existing shares.